TickerFacts.

A business in context

TLPH research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-027316

  2. 8-K · Current report

    Report date 2026-08-12 · 0001437749-26-027311 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-22 · 0001981291-26-000002

  4. 4 · Ownership change

    Report date 2026-06-22 · 0001853794-26-000002

  5. 4 · Ownership change

    Report date 2026-06-22 · 0001774807-26-000005

  6. 4 · Ownership change

    Report date 2026-06-22 · 0001305178-26-000002

  7. 4 · Ownership change

    Report date 2026-06-22 · 0001248144-26-000003

  8. 4 · Ownership change

    Report date 2026-06-22 · 0001190472-26-000002

  9. 4 · Ownership change

    Report date 2026-06-22 · 0001190418-26-000002

  10. 8-K · Current report

    Report date 2026-06-22 · 0001437749-26-021446 · Items 5.02,5.07,9.01

  11. 4 · Ownership change

    Report date 2026-05-20 · 0002040805-26-000005

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-016748

  13. 8-K · Current report

    Report date 2026-05-13 · 0001437749-26-016724 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-22 · 0001437749-26-013895

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-009387

  16. 8-K · Current report

    Report date 2026-03-23 · 0001437749-26-009299 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2026-03-13 · 0001437749-26-008318 · Items 3.02

  18. 8-K · Current report

    Report date 2026-03-11 · 0001437749-26-008217 · Items 3.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-034499

  20. 8-K · Current report

    Report date 2025-11-12 · 0001437749-25-034446 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-10-23 · 0001437749-25-031731 · Items 5.02,5.07,9.01

  22. 8-K · Current report

    Report date 2025-10-20 · 0001437749-25-031468 · Items 3.02,8.01

  23. 8-K · Current report

    Report date 2025-10-14 · 0001437749-25-031162 · Items 5.02

  24. 8-K · Current report

    Report date 2025-09-07 · 0001437749-25-028787 · Items 1.01,3.02,9.01

  25. DEF 14A · Proxy statement

    Report date 2025-10-23 · 0001437749-25-028683

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-027002

  27. 8-K · Current report

    Report date 2025-08-14 · 0001437749-25-026938 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-05-30 · 0001437749-25-019574 · Items 3.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-016898

  30. 8-K · Current report

    Report date 2025-05-14 · 0001437749-25-016840 · Items 2.02,9.01

  31. 10-K/A · Annual report

    Report date 2024-12-31 · 0001437749-25-013536

  32. 8-K · Current report

    Report date 2025-03-31 · 0001437749-25-010729 · Items 1.01,3.02,9.01

  33. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-010250

  34. 8-K · Current report

    Report date 2025-03-31 · 0001437749-25-010190 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2024-12-06 · 0001437749-24-037242 · Items 3.01

  36. 8-K · Current report

    Report date 2024-11-27 · 0001437749-24-036376 · Items 3.01

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-034965

  38. 8-K · Current report

    Report date 2024-11-13 · 0001437749-24-034907 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-09-30 · 0001437749-24-030380 · Items 1.01,9.01

  40. 8-K · Current report

    Report date 2024-08-12 · 0001437749-24-026815 · Items 2.02,5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 14 transaction rows14AExercise / conversion: 0 transaction rows0MTax / exercise payment: 5 transaction rows5FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

19 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-22
2026-06-24
JAIN ABHINAVA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
JAIN ABHINAVA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
Bozilenko MarinaA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
Bozilenko MarinaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
Todisco JosephA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
Todisco JosephA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
Broadfoot Jill MarieA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
Broadfoot Jill MarieA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
ADAMS ADRIANA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
ADAMS ADRIANA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
WAN MARK AA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
WAN MARK AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-06-22
2026-06-24
HOFFMAN STEPHEN JA · Grant / award
Acquired
Common Stock5100.00.0
2026-06-22
2026-06-24
HOFFMAN STEPHEN JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30700.00.0
2026-05-20
2026-05-21
Aslam ShakilF · Tax / exercise payment
Disposed
Common Stock4518.00.82
2026-04-02
2026-04-03
Aslam ShakilF · Tax / exercise payment
Disposed
Common Stock2118.00.72
2026-04-02
2026-04-03
Angotti Vincent J.F · Tax / exercise payment
Disposed
Common Stock9938.00.72
2026-04-02
2026-04-03
ASADORIAN RAFFIF · Tax / exercise payment
Disposed
Common Stock2444.00.72
2026-04-02
2026-04-03
Dasu Badri NF · Tax / exercise payment
Disposed
Common Stock2444.00.72

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001427925TALPHERA, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • AcelRx Pharmaceuticals (United States) · alias · wikidata
  • ACELRX PHARMACEUTICALS INC · former SEC name · 2008-02-19 to 2023-12-14
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$651.0K$713.4K
2022-12-31$0$0
2021-12-31$2.82M$3.47M
2020-12-31$5.42M$6.99M
2019-12-31$2.29M$2.99M
2018-12-31$2.15M$2.86M
2017-12-31$8.00M$10.89M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗